| human | Q5 |
| P7893 | CIÊNCIAVITAE ID | A01C-0511-C986 |
| P496 | ORCID iD | 0000-0002-8537-8744 |
| P166 | award received | Mulheres na Ciência | Q106043504 |
| P27 | country of citizenship | Portugal | Q45 |
| P735 | given name | Helena | Q1035239 |
| Helena | Q1035239 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q61338101 | A position statement on NAFLD/NASH based on the EASL 2009 special conference |
| Q36443799 | Alcoholic disease: understanding the scope of the problem and what we need to do to tackle it. |
| Q92959211 | Anticoagulation in patients with cirrhosis and portal vein thrombosis: Safety and beneficial effect on OLT-free survival |
| Q57760188 | Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis |
| Q61338216 | Are genes really important in alcoholic liver disease? |
| Q46691653 | Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease? |
| Q46604037 | Bile acid levels are increased in the liver of patients with steatohepatitis |
| Q46306589 | Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet |
| Q44121620 | Body composition and body fat distribution are related to cardiac autonomic control in non-alcoholic fatty liver disease patients |
| Q37863134 | Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? |
| Q26752614 | Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet |
| Q46124345 | Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease? |
| Q35668782 | Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal |
| Q36561289 | Hepatic histology in obese patients undergoing bariatric surgery |
| Q37886042 | Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. |
| Q42997997 | Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors. |
| Q28710202 | Hepatitis C and metabolic disorders: genetics, mechanism, and therapies (clinical and experimental) |
| Q57760193 | Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients |
| Q61337885 | How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease |
| Q61337835 | Identifying palliative care needs in a Portuguese liver unit |
| Q37345871 | Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. |
| Q61337967 | Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease |
| Q38033391 | Improving dietary patterns in patients with nonalcoholic fatty liver disease. |
| Q91351902 | Inadvertent oversight while reporting factors predicting decompensation of cirrhosis |
| Q90301733 | Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study |
| Q37122115 | Iron homeostasis and H63D mutations in alcoholics with and without liver disease |
| Q43954619 | Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial |
| Q34168368 | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. |
| Q45022098 | Liver disease-related admissions in Portugal: clinical and demographic pattern |
| Q50649200 | Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia? |
| Q96230912 | NAFLD - sounding the alarm on a silent epidemic |
| Q61338280 | Nash, insulin resistance and iron |
| Q61338029 | No need for a large belly to have NASH |
| Q36186351 | Non-alcoholic fatty liver disease and insulin resistance. |
| Q35961703 | Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. |
| Q38062786 | Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. |
| Q92857005 | Nonalcoholic Fatty Liver Disease versus Alcohol Related Liver Disease: is it really so different? |
| Q47375637 | Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients |
| Q61338068 | Osteopontin: A missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis |
| Q91913795 | Prevalence and risk factors of fatty liver in Portuguese adults |
| Q61338252 | Previous practice of high-intensity sports as a risk factor for non-alcoholic steatohepatitis |
| Q33482537 | Quality of life following liver transplantation: a comparative study between Familial Amyloid Neuropathy and liver disease patients |
| Q91838233 | Reply to: "Caveats for the implementation of global strategies against non-alcoholic fatty liver disease" |
| Q61337819 | Serum vitamin D levels correlate with the presence and histological grading of colorectal adenomas in peri and postmenopausal women |
| Q43042662 | The burden of disease and the cost of illness attributable to alcohol drinking--results of a national study |
| Q61338054 | The dark side of sports: using steroids may harm your liver |
| Q61337901 | The new definition of acute kidney injury in patients with cirrhosis: a critical look |
| Q51747132 | Uncoupling proteins and non-alcoholic fatty liver disease. |
| Q61338084 | [Intra-gastric ballon in the treatment of morbid obesity] |
| Q61338143 | [Malnutrition in morbid obesity] |
| Q60895711 | miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease |
Search more.